Ausgabe 12/2017
Inhalt (19 Artikel)
Are Eating Disorders Risk Factors for Type 2 Diabetes? A Systematic Review and Meta-analysis
Ramfis Nieto-Martínez, Juan P. González-Rivas, José R. Medina-Inojosa, Hermes Florez
Alcohol Consumption, Diabetes Risk, and Cardiovascular Disease Within Diabetes
Sarit Polsky, Halis K. Akturk
Health Benefits of Fasting and Caloric Restriction
Saeid Golbidi, Andreas Daiber, Bato Korac, Huige Li, M. Faadiel Essop, Ismail Laher
Understanding Cultural Influences on Dietary Habits in Asian, Middle Eastern, and Latino Patients with Type 2 Diabetes: A Review of Current Literature and Future Directions
Natalie Mora, Sherita Hill Golden
Modifiable Risk Factors for Cardiovascular Disease in Children with Type 1 Diabetes: Can Early Intervention Prevent Future Cardiovascular Events?
Evgenia Gourgari, Dana Dabelea, Kristina Rother
The Infamous, Famous Sulfonylureas and Cardiovascular Safety: Much Ado About Nothing?
Laurentiu M. Pop, Ildiko Lingvay
Insulin and Its Cardiovascular Effects: What Is the Current Evidence?
Sahana Pai Dongerkery, Pamela R. Schroeder, Mansur E. Shomali
Cardiometabolic Risk in PCOS: More than a Reproductive Disorder
Laura C. Torchen
Disentangling the Role of Melatonin and its Receptor MTNR1B in Type 2 Diabetes: Still a Long Way to Go?
Amélie Bonnefond, Philippe Froguel
A Decade of Genetic and Metabolomic Contributions to Type 2 Diabetes Risk Prediction
Jordi Merino, Miriam S. Udler, Aaron Leong, James B. Meigs
Cardiorespiratory Fitness and Cardiac Autonomic Function in Diabetes
Martin Röhling, Alexander Strom, Gidon J. Bönhof, Michael Roden, Dan Ziegler
Treatment-Induced Neuropathy of Diabetes
Christopher H. Gibbons
Genetic Risk Scores for Type 1 Diabetes Prediction and Diagnosis
Maria J. Redondo, Richard A. Oram, Andrea K. Steck
Autoimmune Responses to Exosomes and Candidate Antigens Contribute to Type 1 Diabetes in Non-Obese Diabetic Mice
Yang D. Dai, Huiming Sheng, Peter Dias, M. Jubayer Rahman, Roman Bashratyan, Danielle Regn, Kristi Marquardt
Current Therapies That Modify Glucagon Secretion: What Is the Therapeutic Effect of Such Modifications?
Magnus F. Grøndahl, Damien J. Keating, Tina Vilsbøll, Filip K. Knop
Hypoglycemia Reduction Strategies in the ICU
Susan Shapiro Braithwaite, Dharmesh B. Bavda, Thaer Idrees, Faisal Qureshi, Oluwakemi T. Soetan
Glucometrics and Insulinometrics
Bithika M. Thompson, Curtiss B. Cook
Reporting Severe Hypoglycemia in Type 1 Diabetes: Facts and Pitfalls
Ulrik Pedersen-Bjergaard, Birger Thorsteinsson
Persistent Organic Pollutants as Risk Factors for Obesity and Diabetes
Chunxue Yang, Alice Pik Shan Kong, Zongwei Cai, Arthur C.K. Chung